Search Results - "del Potro, Eloy"

Treatment of high-risk Philadelphia chromosome-negative acute lymphoblastic leukemia in adolescents and adults according to early cytologic response and minimal residual disease after consolidation assessed by flow cytometry: final results of the PETHEMA ALL-AR-03 trial by Ribera, Josep-Maria, Oriol, Albert, Morgades, Mireia, Montesinos, Pau, Sarrà, Josep, González-Campos, José, Brunet, Salut, Tormo, Mar, Fernández-Abellán, Pascual, Guàrdia, Ramon, Bernal, María-Teresa, Esteve, Jordi, Barba, Pere, Moreno, María-José, Bermúdez, Arancha, Cladera, Antonia, Escoda, Lourdes, García-Boyero, Raimundo, Del Potro, Eloy, Bergua, Juan, Amigo, María-Luz, Grande, Carlos, Rabuñal, María-José, Hernández-Rivas, Jesús-María, Feliu, Evarist

“…Minimal residual disease (MRD) is an important prognostic factor in adults with acute lymphoblastic leukemia (ALL) and may be used for treatment decisions. The…”
Get full text

Comparison of the Results of the Treatment of Adolescents and Young Adults With Standard-Risk Acute Lymphoblastic Leukemia With the Programa Español de Tratamiento en Hematología Pediatric-Based Protocol ALL-96 by RIBERA, Josep-Maria, ORIOL, Albert, GRANDE, Carlos, HERAS, Inmaculada, BETHENCOURT, Concepcion, FELIU, Evarist, ORTEGA, Juan-José, SANZ, Miguel-Angel, TORMO, Mar, FERNANDEZ-ABELLAN, Pascual, DEL POTRO, Eloy, ABELLA, Eugenia, BUENO, Javier, PARODY, Ricardo, BASTIDA, Pilar

“…Retrospective studies have shown that adolescents and young adults with acute lymphoblastic leukemia (ALL) treated with pediatric protocols have better…”
Get full text

Outcome after relapse of acute lymphoblastic leukemia in adult patients included in four consecutive risk-adapted trials by the PETHEMA Study Group by ORIOL, Albert, VIVES, Susana, DEL POTRO, Eloy, GUARDIA, Ramon, BRUNET, Salut, BERGUA, Juan, BERNAL, Teresa, MORENO, Maria-José, CALVO, Carlota, BASTIDA, Pilar, FELIU, Evarist, RIBERA, Josep-Maria, HERNANDEZ-RIVAS, Jesús-María, TORMO, Mar, HERAS, Inmaculada, RIVAS, Concepción, BETHENCOURT, Concepción, MOSCARDO, Federico, BUENO, Javier, GRANDE, Carlos

“…About one half of adults with acute lymphoblastic leukemia are not cured of the disease and ultimately die. The objective of this study was to explore the…”
Get full text

Concurrent intensive chemotherapy and imatinib before and after stem cell transplantation in newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia. Final results of the CSTIBES02 trial by RIBERA, Josep-Maria, ORIOL, Albert, MARTIN-REINA, Victoria, SARRA, Josep, PARODY, Ricardo, PEREZ DE OTEYZA, Jaime, BUREO, Encarna, VERNAL, Maria-Teresa, GONZALEZ, Marcos, VIDRIALES, Belén, BRUNET, Salut, ESTEVE, Jordi, DEL POTRO, Eloy, RIVAS, Concepción, MORENO, Maria-José, TORMO, Mar

“…Imatinib, given concurrently or alternating with chemotherapy, has improved the response and survival of patients with Philadelphia chromosome-positive acute…”
Get full text

Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia by Sancho, Juan-Manuel, Ribera, Josep-Maria, Xicoy, Blanca, Morgades, Mireia, Oriol, Albert, Tormo, Mar, Potro, Eloy del, Debén, Guillermo, Abella, Eugenia, Bethencourt, Concepción, Ortín, Xavier, Brunet, Salut, Ortega-Rivas, Fernando, Novo, Andrés, López, Ramón, Hernández-Rivas, Jesús-María, Sanz, Miguel-Angel, Feliu, Evarist

“…Background and aim: Only 20–30% of elderly patients with acute lymphoblastic leukemia (ALL) are enrolled in clinical trials because of co‐morbid disorders or…”
Get full text

Comparison of Intensive Chemotherapy, Allogeneic, or Autologous Stem-Cell Transplantation As Postremission Treatment for Children With Very High Risk Acute Lymphoblastic Leukemia: PETHEMA ALL-93 Trial by Ribera, Jose-Maria, Ortega, Juan-José, Oriol, Albert, Bastida, Pilar, Calvo, Carlota, Pérez-Hurtado, José-María, González-Valentín, María-Elvira, Martín-Reina, Victoria, Molinés, Antonio, Ortega-Rivas, Fernando, Moreno, Maria-José, Rivas, Concepción, Egurbide, Izaskun, Heras, Inmaculada, Poderós, Concepción, Martínez-Revuelta, Eva, Guinea, José-Maria, del Potro, Eloy, Deben, Guillermo

“…The optimal postremission therapy for children with very high-risk (VHR) acute lymphoblastic leukemia (ALL) is not well established. This randomized trial…”
Get full text

Relapsing pancytopenia following exposure and re-exposure to cyanamide by Prieto Yerro, Concepción, Pérez López, Cristina, Rodriguez Bernardino, Angel, Martinez Martinez, Rafael, Del Potro Gómez, Eloy, Alvarez Carmona, Ana

Get full text

Prognostic significance of complex karyotype and monosomal karyotype in adult patients with acute lymphoblastic leukemia treated with risk‐adapted protocols by Motlló, Cristina, Ribera, Josep‐María, Morgades, Mireia, Granada, Isabel, Montesinos, Pau, González‐Campos, José, Fernández‐Abellán, Pascual, Tormo, Mar, Bethencourt, Concepción, Brunet, Salut, Hernández‐Rivas, Jesús‐María, Moreno, María‐José, Sarrà, Josep, del Potro, Eloy, Barba, Pere, Bernal, Teresa, Grande, Carlos, Grau, Javier, Cervera, José, Feliu, Evarist

“…BACKGROUND The karyotype is a predictor of outcomes in adults with acute lymphoblastic leukemia (ALL). The unfavorable prognostic significance of complex…”
Get full text

Frequency and prognostic significance of t(v;11q23)/KMT2A rearrangements in adult patients with acute lymphoblastic leukemia treated with risk-adapted protocols by Motlló, Cristina, Ribera, Josep-Maria, Morgades, Mireia, Granada, Isabel, Montesinos, Pau, Brunet, Salut, Bergua, Juan, Tormo, Mar, García-Boyero, Raimundo, Sarrà, Josep, del Potro, Eloy, Grande, Carlos, Barba, Pere, Bernal, Teresa, Amigo, María-Luz, Grau, Javier, Cervera, José, Feliu, Evarist

“…The karyotype is an important predictor of outcome in acute lymphoblastic leukemia (ALL). Rearrangements of the 11q23 region involving the KMT2A gene confer an…”
Get full text

Dose-intensive chemotherapy including rituximab is highly effective but toxic in human immunodeficiency virus-infected patients with Burkitt lymphoma/leukemia: parallel study of 81 patients by Xicoy, Blanca, Ribera, Josep-Maria, Müller, Markus, García, Olga, Hoffmann, Christian, Oriol, Albert, Hentrich, Marcus, Grande, Carlos, Wasmuth, Jan-Christian, Esteve, Jordi, van Lunzen, Jan, del Potro, Eloy, Knechten, Heribert, Brunet, Salut, Mayr, Christoph, Escoda, Lourdes, Schommers, Philipp, Alonso, Natalia, Vall-llovera, Ferran, Pérez, Montserrat, Morgades, Mireia, González, José, Fernández, Angeles, Thoden, Jan, Gökbuget, Nicola, Hoelzer, Dieter, Fätkenheuer, Gerd, Wyen, Christoph

“…Abstract The results of intensive immunochemotherapy were analyzed in human immunodeficiency virus (HIV)-related Burkitt lymphoma/leukemia (BLL) in two cohorts…”
Get full text

Comparison of intensive chemotherapy, allogeneic or autologous stem cell transplantation as post-remission treatment for adult patients with high-risk acute lymphoblastic leukemia. Results of the PETHEMA ALL-93 trial by Ribera, JM, Oriol, A, Bethencourt, C, Parody, R, Hernandez-Rivas, JM, Moreno, MJ, del Potro, E, Torm, M, Rivas, C, Besalduch, J, Sanz, MA, Ortega, JJ, PETHEMA Group, Spain

“…Servicio de Hematologia Clinica, Institut Catala d'Oncologia-Hospital Universitari Germans Trias i Pujol, C/ Canyet S/N, 08916 Badalona, Spain…”
Get full text

Prognostic Value of Complex Karyotype and Monosomal Karyotype in Patients with Adult Acute Lymphoblastic Leukemia Treated with Risk-Adapted Protocols by Motlló, Cristina, Ribera, Josep-Maria, Morgades, Mireia, Granada, Isabel, Grau, Javier, Montesinos, Pau, González-Campos, José, Fernández-Abellán, Pascual, Tormo, Mar, Bethencourt, Concha, Brunet, Salut, Hernández-Rivas, Jesús M, Moreno, MJ, Sarra, Jose, Del Potro, Eloy, Barba, Pere, Bernal, Teresa, Amigo, Maria-Luz, Grande, Carlos, Bermudez, Arancha, Guardia, Ramon, Llorente, Andrés, Peñarrubia, Maria Jesús, Arias, Jesús, Sanz, Miguel Angel, Feliu, Evarist

“…Abstract 4785 The karyotype is an important predictor of outcome in adults with acute lymphoblastic leukemia (ALL). Some groups have reported the negative…”
Get full text

Clofarabine-Based Chemotherapy for Relapsed/Refractory Adult Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma. the Spanish Experience by Barba, Pere, Sampol, Antonia, Calbacho, María, Gonzalez, Jose, Serrano, Josefina, Martinez-Sanchez, Pilar, Fernandez, Pascual, Garcia-Boyero, Raimundo, Martino, Rodrigo, Delgado, Pilar, Hernandez-rivas, Jose Angel, Del Potro, Eloy, Gonzalez-Muñiz, Soledad, Gomez-Sanchez, MAria Isabel, de la Fuente, Adolfo, Bueno, Javier, Ribera, Josep-Maria

“…Abstract 4246 Patients with relapsed/refractory acute lymphoblastic leukemia (ALL) have a very poor outcome with limited therapeutic options available…”
Get full text

Comparison of Short-Term Outcomes Between CSTIBES02 and ALL Ph08 Trials for Young Patients with Philadephia Chromosome-Positive ALL (Ph+ALL) Differing In Imatinib Dose and Amount of Chemotherapy Before Stem Cell Transplantation by Ribera, Josep-Maria, Garcia, Olga, Montesinos, Pau, Barrios, Manuel, Oriol, Albert, Brunet, Salut, Gonzalez, Jose, Esteve, Jordi, Tormo, Mar, Potro, Eloy Del, Moreno, Maria-José, Fernández-Abellán, Pascual, Hernández-Rivas, Jesú S. M.a, Barba, Pere, Sarrá, Josep, Abella, Eugènia, Bernal, Maria-Teresa, Llorente, Andreu, Amigo, Maria-Luz, Lavilla, Esperanza, Bravo, Pilar, Sanz, Miguel-Angel, Feliu, Evarist

“…Abstract 2582 Concurrent imatinib and chemotherapy followed by allogeneic stem cell transplantation (SCT) is the most used treatment for young patients with…”
Get full text

Specific Chemotherapy and Rituximab In HIV-Infected Patients with Burkitt's Leukemia or Lymphoma. Results of a German-Spanish Study and Analysis of Prognostic Factors by Ribera, Josep-Maria, Wyen, Christoph, Morgades, Mireia, Hoffmann, Christian, Oriol, Albert, Fätkenheuer, Gerd, Grande, Carlos, Mueller, Markus, Esteve, Jordi, Wasmuth, Jan-Christian, Del Potro, Eloy, van Lunzen, Jan, Brunet, Salut, Knechten, Heribert, Escoda, Lourdes, Hammond, Angela, Alonso, Nuria, Hentrich, Marcus, Vall-llovera, Ferran, Mayr, Christoph, Perez, Montserrat, Thoden, Jan, Garcia, Olga, Sternfeld, Thomas, Wolf, Timo, Sanz, Miguel-Angel, Hoelzer, Dieter

“…Abstract 3944 Background and objective. Specific immunochemotherapy has provided promising results in HIV-infected patients with Burkitt's leukemia or lymphoma…”
Get full text

Highly active antiretroviral therapy and outcome of AIDS-related Burkitt's lymphoma or leukemia. Results of the PETHEMA-LAL3/97 study by Oriol, A, Ribera, JM, Brunet, S, del Potro, E, Abella, E, Esteve, J

“…Short, intensive cycles of chemotherapy have resulted in improved survival in BurkittOs lymphoma/leukemia (BL) in adults. The prognosis of patients with…”
Get full text

Treatment of High-Risk (HR) Philadelphia Chromosome-Negative (Ph-) Adult Acute Lymphoblastic Leukemia (ALL) According to Baseline Risk Factors and Minimal Residual Disease (MRD). Results of the PETHEMA ALL-AR-03 Trial Including the Use of Propensity Score (PS) Method to Reduce Assignment Bias by Ribera, Josep-Maria, Oriol, Albert, Morgades, Mireia, Sanz, Miguel-Angel, Montesinos, Pau, Sarra, Josep, Brunet, Salut, Fernández-Abellan, Pascual, Guardia, Ramon, Esteve, Jordi, Gonzalez-Campos, Jose, Bermudez, Arancha, Moreno, Maria-Jose, Bernal, Maria-Teresa, Tormo, Mar, Del Potro, Eloy, Cladera, Antonia, Llorente, Andreu, Garcia-Boyero, Raimundo, Rabuñal, Maria-Jose, Bergua, Juan, Grande, Carlos, Amigo, Maria-Luz, Bueno, Javier, Bethencourt, Concepcion, Hernandez-Rivas, Jesus-Maria, Feliu, Evarist

“…Abstract 322 Current therapeutic protocols for adult ALL consider MRD together with the baseline risk factors (age, WBC count, immunophenotype, cytogenetics)…”
Get full text

Treatment of High-Risk (HR) Philadelphia Chromosome-Negative (Ph-) Adult Acute Lymphoblastic Leukemia (ALL) According to Baseline Risk Factors and Minimal Residual Disease (MRD). Results of the PETHEMA ALL-AR-03 Trial by Ribera, Josep-Maria, Oriol, Albert, Morgades, Mireia, Sarra, Josep, Montesinos, Pau, Brunet, Salut, Guardia, Ramon, Fernández-Abellan, Pascual, Bernal, Teresa, Bermudez, Arancha, Moreno, Maria-Jose, Parody, Ricardo, Tormo, Mar, Potro, Eloy Del, Llorente, Andreu, Garcia-Boyero, Raimundo, Esteve, Jordi, Rabuñal, Maria-Jose, Pardal, Emilia, Grande, Carlos, Bueno, Javier, Cladera, Antonia, Bethencourt, Concepcion, Martin-Reina, Victoria, Amigo, Maria-Luz, Hernandez-Rivas, Jesus-Maria, Sanz, Miguel-Angel, Feliu, Evarist

“…Background and aim: Current therapeutic protocols for adult ALL consider MRD together with the baseline risk factors (age, WBC count, immunophenotype,…”
Get full text

The Prognostic Significance of Complex Karyotype in Philadelphia Chromosome-Negative (Ph−) Acute Lymphoblastic Leukemia (ALL) in Adults Is Related with Risk Group by Granada, Isabel, Sancho, Juan-Manuel, Oriol, Albert, Morgades, Mireia, Bethencourt, Concepción, Parody, Ricardo, Hernández-Rivas, Jesús-María, Moreno, Maria-José, Del-Potro, Eloy, Tormo, Mar, Rivas, Concepción, Sanz, Miguel-Angel, Grande, Carlos, Bueno, Javier, Abella, Eugenia, Ortega, Juan-José, Ribera, Josep-Maria

“…Different from acute myeloblastic leukemia, the prognostic significance of complex karyotype (CK) is not well known in adults with ALL. A recent study showed…”
Get full text

Treatment of High-Risk (HR) Philadelphia Chromosome-Negative (Ph-) Adult Acute Lymphoblastic Leukemia (ALL) According to Classical Risk Factors and Minimal Residual Disease (MRD). Interim Results of the PETHEMA ALL-AR-03 Trial by Ribera, Josep, Oriol, Albert, Morgades, Mireia, Sarrá, Josep, Brunet, Salut, Llorente, Andreu, Guardia, Ramon, Parody, Ricardo, Bernal, Teresa, Esteve, Jordi, Sanz, Miguel, Potro, Eloy Del, Bergua, Juan, Moreno, Maria-Jose, Grande, Carlos, Bueno, Javier, Cladera, Antonia, Fernández, María-Carmen, García-Boyero, Raimundo, Bermúdez, Arancha, Feliu, Evarist

“…Current therapeutic protocols for adult ALL consider MRD together with the classical risk factors (age, WBC count, immunophenotype, cytogenetics and speed in…”
Get full text